Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Dibirdik I et al. | 2000 | intact cell/cell culture, DT40 (chicken lymphoma B-cells) and NALM-6 cells (B cell precursor leukemia cells) | magnetic field, 50/60 Hz, shielding/field deprivation | 100 µT |
Nie K et al. | 2003 | intact cell/cell culture, HL-60 cells (human acute myeloid leukaemia cell line), MCF-7 cells (breast cancer cell line), 3Y1 cells (rat fibroblast cells) | magnetic field, 50/60 Hz, shielding/field deprivation | 100 µT |
Nazar AS et al. | 1994 | bacterium, <i>Escherichia coli</i> | magnetic field, low frequency, 50/60 Hz | 138.48 nT |
Litovitz TA et al. | 1991 | intact cell/cell culture, L929 cells (murine fibroblast cells) | magnetic field, low frequency, 50/60 Hz | 1–100 µT |
Chen C et al. | 2009 | organelle/cell part, chromatophore suspensions prepared from bacteria | magnetic field, low frequency, 50/60 Hz | 0.1–0.5 mT |
Akpolat V et al. | 2009 | animal, rat/Sprague-Dawley, whole body | magnetic field, low frequency, 50/60 Hz | 1.5 mT |
Song HS et al. | 2010 | intact cell/cell culture, RBL-2H3 (rat basophilic leukemia cells) and RAW 264.7 (murine macrophage cells) | magnetic field, low frequency, 50/60 Hz | 0.1–1 mT |
Batcioglu K et al. | 2011 | isolated bio./chem. substance, enzyme solutions of adenosine deaminase and xanthine oxidase | magnetic field, low frequency, 50/60 Hz | 5.8 mT |
Patruno A et al. | 2011 | intact cell/cell culture, THP-1 cells (human monocytic leukemia cell line) and HaCaT cells (human keratinocytes) | magnetic field, low frequency, 50/60 Hz | 1 mT |
Zhong C et al. | 2012 | intact cell/cell culture, mesenchymal bone marrow stem cells of mice (rat?, remark EMF-Portal: contradictory information) | magnetic field, low frequency, 50/60 Hz | 0.5 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.